973 related articles for article (PubMed ID: 17306971)
41. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
42. Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies.
Groen RW; Oud ME; Schilder-Tol EJ; Overdijk MB; ten Berge D; Nusse R; Spaargaren M; Pals ST
Cancer Res; 2008 Sep; 68(17):6969-77. PubMed ID: 18757411
[TBL] [Abstract][Full Text] [Related]
43. WNT signaling pathway and stem cell signaling network.
Katoh M; Katoh M
Clin Cancer Res; 2007 Jul; 13(14):4042-5. PubMed ID: 17634527
[TBL] [Abstract][Full Text] [Related]
44. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
[TBL] [Abstract][Full Text] [Related]
45. Wnt signaling controls the fate of mesenchymal stem cells.
Ling L; Nurcombe V; Cool SM
Gene; 2009 Mar; 433(1-2):1-7. PubMed ID: 19135507
[TBL] [Abstract][Full Text] [Related]
46. The Wnt/beta-catenin pathway in adrenocortical development and cancer.
El Wakil A; Lalli E
Mol Cell Endocrinol; 2011 Jan; 332(1-2):32-7. PubMed ID: 21094679
[TBL] [Abstract][Full Text] [Related]
47. STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer (Review).
Katoh M; Katoh M
Int J Mol Med; 2007 Feb; 19(2):273-8. PubMed ID: 17203201
[TBL] [Abstract][Full Text] [Related]
48. Roles of Wnt/beta-catenin signaling in epithelial differentiation of mesenchymal stem cells.
Wang Y; Sun Z; Qiu X; Li Y; Qin J; Han X
Biochem Biophys Res Commun; 2009 Dec; 390(4):1309-14. PubMed ID: 19879238
[TBL] [Abstract][Full Text] [Related]
49. An oncogenic hub: beta-catenin as a molecular target for cancer therapeutics.
Takemaru KI; Ohmitsu M; Li FQ
Handb Exp Pharmacol; 2008; (186):261-84. PubMed ID: 18491056
[TBL] [Abstract][Full Text] [Related]
50. Wnt signaling inhibits cementoblast differentiation and promotes proliferation.
Nemoto E; Koshikawa Y; Kanaya S; Tsuchiya M; Tamura M; Somerman MJ; Shimauchi H
Bone; 2009 May; 44(5):805-12. PubMed ID: 19442631
[TBL] [Abstract][Full Text] [Related]
51. Rough surface topography enhances the activation of Wnt/β-catenin signaling in mesenchymal cells.
Galli C; Passeri G; Ravanetti F; Elezi E; Pedrazzoni M; Macaluso GM
J Biomed Mater Res A; 2010 Dec; 95(3):682-90. PubMed ID: 20725985
[TBL] [Abstract][Full Text] [Related]
52. Beta-catenin signaling contributes to stemness and regulates early differentiation in murine embryonic stem cells.
Anton R; Kestler HA; Kühl M
FEBS Lett; 2007 Nov; 581(27):5247-54. PubMed ID: 17950287
[TBL] [Abstract][Full Text] [Related]
53. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
[TBL] [Abstract][Full Text] [Related]
54. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling.
Malanchi I; Peinado H; Kassen D; Hussenet T; Metzger D; Chambon P; Huber M; Hohl D; Cano A; Birchmeier W; Huelsken J
Nature; 2008 Apr; 452(7187):650-3. PubMed ID: 18385740
[TBL] [Abstract][Full Text] [Related]
55. Role of the Wnt/beta-catenin network in regulating hematopoiesis.
Wilusz M; Majka M
Arch Immunol Ther Exp (Warsz); 2008; 56(4):257-66. PubMed ID: 18726147
[TBL] [Abstract][Full Text] [Related]
56. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
[TBL] [Abstract][Full Text] [Related]
57. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L
Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685
[TBL] [Abstract][Full Text] [Related]
58. Patterns of Wnt pathway activity in the mouse incisor indicate absence of Wnt/beta-catenin signaling in the epithelial stem cells.
Suomalainen M; Thesleff I
Dev Dyn; 2010 Jan; 239(1):364-72. PubMed ID: 19806668
[TBL] [Abstract][Full Text] [Related]
59. Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology.
Caricasole A; Bakker A; Copani A; Nicoletti F; Gaviraghi G; Terstappen GC
Biosci Rep; 2005; 25(5-6):309-27. PubMed ID: 16307379
[TBL] [Abstract][Full Text] [Related]
60. SATB1 and colorectal cancer in Wnt/β-catenin signaling: Is there a functional link?
Meng WJ; Yan H; Li Y; Zhou ZG
Med Hypotheses; 2011 Feb; 76(2):277-9. PubMed ID: 21122998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
